Effective immunosupression management is central to achieving optimal outcomes in liver
transplant recipients. Current immunosuppression regimens and agents are highly effective …

Advancements in surgical technique and perioperative management have improved both
short-and long-term outcomes in children undergoing liver transplantation for various …

Background and Aims Tolerance is transplantation's holy grail, as it denotes allograft health
without immunosuppression and its toxicities. Our aim was to determine, among stable long …

Background & Aims A substantial proportion of pediatric liver transplant recipients develop
subclinical chronic allograft injury. We studied whether there are distinct patterns of injury …

Background SPLIT was founded in 1995 in order to collect comprehensive prospective data
on pediatric liver transplantation, including waiting list data, transplant, and early and late …

VC 2013 American Association for the Study of Liver Diseases. of the American Association
for the Study of Liver Diseases requires a class (reflecting the benefit versus the risk) and …

Pediatric liver transplantation has experienced improved outcomes over the last 50 years.
This can be attributed in part to establishing optimal use of immunosuppressive agents to …

Background. In the United States, 1 in 10 infants and 1 in 20 older children die on the liver
transplant waiting list. Increasing split liver transplantation could increase organ availability …

Long-term outcomes remain suboptimal following pediatric liver transplantation; only one
third of children have normal biochemical liver function without immunosuppressant …

Liver transplantation (LTx) was initially developed as a therapy for liver diseases known to
be associated with a high risk of near-term mortality but is based upon a different set of …